drugset / Trial / NCT02940184
GLP-1 Signaling in Truncally Vagotomized Subjects
RandomizedCrossoverOpen-labelBasic science
Summary
Investigation of the importance of vagal signaling for the glucohomeostatic effects of GLP-1. The study will include physiological studies of truncally vagotomized participants and matched controls.
Timeline
- Start
- 2016-06
- Primary completion
- 2018-10
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 100 mg | — |
Indications
No indication recorded.